Skip Navigation LinksHome > October 2013 - Volume 17 - Issue 4 > Vaginal Cancer: The Experience From 2 Large Academic Center...
Journal of Lower Genital Tract Disease:
doi: 10.1097/LGT.0b013e3182800ee2
Original Articles

Vaginal Cancer: The Experience From 2 Large Academic Centers During a 15-Year Period

Gunderson, Camille C. MD1; Nugent, Elizabeth K. MD1; Yunker, Amanda C. DO, MSCR1; Rocconi, Rodney P. MD2; Graybill, Whitney S. MD2; Erickson, Britt K. MD2; Moore, Kathleen N. MD, MS1

Collapse Box


Objective: Limited data regarding the natural history, management, and prognosis of vaginal cancer exist owing to the relative disease rarity.

Materials and Methods: A retrospective chart review was performed at 2 institutions to identify women receiving treatment for vaginal cancer between 1990 and 2004. Demographics, risk factors, histology, International Federation of Gynecology and Obstetrics stage, treatment, and treatment-related complications were recorded. Statistical Analysis Software (SAS) version 9.2 was used.

Results: A total of 110 patients were identified in the 2 university databases. Median age was 63 years (range = 36–93 years), and 84% were white; 73% had squamous cell carcinoma, 40% were ever users of tobacco, and 64% had no abnormal Pap smear results. Of the patients, 83% had early-stage (I or II) disease. Treatment varied by stage with increasing use of radiation with advancing stage. Recurrence was 24%, 32%, and 53% for stage I, II, and III/IV disease, respectively. After a median follow-up of 21 months, progression-free survival was 59, 35, and 23 months for stage I, II, and III/IV disease, respectively. Overall survival was 106, 58, and 34 months for stage I, II, and III/IV disease, respectively. Age greater than 60 years (p = .0339; hazard ratio [HR] = 2.162), advanced stage (p = .0004; HR = 2.475), and tobacco use (p = .0004; HR = 1.02) were negatively associated with survival. Thirty percent developed a significant complication (fistula, stricture, cystitis, or proctitis), and 21% developed a vesicovaginal and/or rectovaginal fistula. There was no association of fistula development with age, stage, tobacco use, histological finding, or treatment history (including radiation therapy).

Conclusions: Age, stage, and tobacco abuse seem to be negatively associated with survival in vaginal cancer. However, no risk factors were associated with fistula development.

Copyright © 2013 by the American Society for Colposcopy and Cervical Pathology


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.